What is eosinophilia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Eosinophilia Definition and Classification

Eosinophilia is defined as a peripheral blood eosinophil count greater than 0.45 × 10^9/L (450 cells/μL). 1

Classification of Eosinophilia

  • Eosinophilia can be classified based on severity:

    • Mild: 500-1500 cells/μL 2
    • Moderate: 1500-5000 cells/μL 2
    • Severe: >5000 cells/μL 2, 3
  • Hypereosinophilia (HE) is defined as a persistent elevated eosinophil count >1.5 × 10^9/L in blood on two examinations at least one month apart and/or tissue hypereosinophilia 1, 4

Types of Hypereosinophilia

Hypereosinophilia is classified into four main variant types:

  • Hereditary (familial) HE: Characterized by familial clustering without signs of hereditary immunodeficiency 4
  • Primary (clonal/neoplastic) HE: Characterized by neoplastic proliferation of eosinophils, associated with WHO-defined myeloid and/or lymphoid neoplasms 4
  • Secondary (reactive) HE: Caused by an underlying condition where eosinophils are non-clonal and usually cytokine-driven (particularly IL-5) 4
  • HE of undetermined significance (HE-US): No underlying cause identified and no family history 4

Tissue Hypereosinophilia

Tissue hypereosinophilia can be defined by one of the following criteria:

  • Percentage of eosinophils in bone marrow exceeds 20% of all nucleated cells 4
  • Pathologist assessment that tissue infiltration by eosinophils is extensive 4
  • Marked deposition of eosinophil granule proteins 4

Organ-Specific Eosinophilia

  • Eosinophilic Esophagitis (EoE) is defined as ≥15 eosinophils/high power field (or ≥15 eosinophils/0.3 mm² or >60 eosinophils/mm²) in esophageal biopsies 1
  • EoE is characterized by symptoms of dysphagia and/or food impaction in adults, and feeding problems, abdominal pain, and/or vomiting in children 1

Common Causes of Eosinophilia

  • Helminth infections are the most common identifiable cause of eosinophilia in returning travelers, with diagnosis rates ranging from 19-80% 1, 5
  • Medications are among the most common non-infectious causes in countries with low rates of endemic helminth infections 5
    • Common culprits include NSAIDs, beta-lactam antibiotics, and nitrofurantoin 1, 5
  • Allergic disorders, including asthma, eczema, and hay fever 1
  • Myeloproliferative disorders should be considered with eosinophil counts >20,000 cells/μL 2
  • Other causes include vasculitis, immunodeficiency diseases, and malignancies 2, 6

Clinical Implications

  • Even mild persistent eosinophilia can cause end-organ damage if left untreated 1, 5
  • Eosinophils may directly damage organs, particularly the heart, lungs, and skin, through the release of granule products, lipid mediators, and cytokines 2
  • Patients with eosinophilia ≥1.5 × 10^9/L for more than 3 months without evidence of end-organ damage should be referred to a hematologist after exclusion of infectious causes 1, 4

Important Considerations

  • Strongyloides stercoralis infection can persist lifelong and later present as hyperinfection syndrome with high mortality in immunocompromised patients 1, 5
  • Testing for eosinophilia alone is not an adequate screening strategy for helminth infection, as many people with helminth infections do not have eosinophilia 5
  • In cases of evolving life-threatening end-organ damage, diagnosis and treatment should be expedited 4

References

Guideline

Eosinophilia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Differential diagnosis of hypereosinophilia].

Zeitschrift fur Rheumatologie, 2019

Guideline

Hypereosinophilia Definition and Classification

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Eosinophilia Management Guideline

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.